GE HealthCare's MIM Software Announces FDA Clearance of Monte Carlo Dosimetry for Theranostics
October 04, 2024
October 04, 2024
CHICAGO, Illinois, Oct. 4 -- G.E. HealthCare issued the following news release on Oct. 3, 2024:
* * *
* The addition of Monte Carlo dosimetry solidifies GE HealthCare and MIM Software's position as a leading provider of comprehensive, vendor-neutral dosimetry tools for Theranostics
* With this clearance, fast Monte Carlo dosimetry via the Dose Planning Method will be available for use with MIM SurePlan MRT on existing hospital hardware
* * . . .
* * *
* The addition of Monte Carlo dosimetry solidifies GE HealthCare and MIM Software's position as a leading provider of comprehensive, vendor-neutral dosimetry tools for Theranostics
* With this clearance, fast Monte Carlo dosimetry via the Dose Planning Method will be available for use with MIM SurePlan MRT on existing hospital hardware
* * . . .